A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  1986-04-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.11213/TONYOBYO1958.29.SPPL1_21PMID 2421135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improvement of peripheral nerve function after institution of insulin treatment in diabetes mellitus. A case-control study.

  2009cited by this paper
• Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjects

  2004cited by this paper
• Glucose-induced Alterations in Nerve Metabolism: Current Perspective on the Pathogenesis of Diabetic Neuropathy and Future Directions for Research and Therapy

  1985cited by this paper
• Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy

  1985cited by this paper
• Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat.

  1984cited by this paper
• Peripheral nerve function and metabolic control in diabetes mellitus

  1984cited by this paper
• Action of Sorbinil in Diabetic Peripheral Nerve: Relationship of Polyol (Sorbitol) Pathway Inhibition to a myo-Inositol-mediated Defect in Sodium-Potassium ATPase Activity

  1984cited by this paper
• Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve.

  1984cited by this paper
• Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals *

  1983cited by this paper
• Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.

  1983cited by this paper
• Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate

  1983cited by this paper
• Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats.

  1983cited by this paper
• The natural history of acute painful neuropathy in diabetes mellitus.

  1983cited by this paper
• Polyol Pathway Activity and Myo-Inositol Metabolism: A Suggested Relationship in the Pathogenesis of Diabetic Neuropathy

  1983cited by this paper
• Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.

  1983cited by this paper
• Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function.

  1983cited by this paper
• Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

  1983cited by this paper
• Sorbitol, inositol and nerve conduction in diabetes.

  1983cited by this paper
• Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus.

  1982cited by this paper
• Continuous Subcutaneous Insulin Infusion in the Management of Painful Diabetic Neuropathy

  1982cited by this paper
• Improvement of Diabetic Peripheral Neuropathy With the Portable Insulin Infusion Pump

  1982cited by this paper
• The Effect of Aldose Reductase Inhibition on Motor Nerve Conduction Velocity in Diabetic Rats

  1982cited by this paper
• Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.

  1982cited by this paper
• Comparison of Clinical Course and Sequential Electrophysiological Tests in Diabetics with Symptomatic Polyneuropathy and its Implications for Clinical Trials

  1981cited by this paper
• Effects of Acute Experimental Diabetes on Composite Energy Metabolism in Peripheral Nerve Axons and Schwann Cells

  1981cited by this paper
• Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.

  1981cited by this paper
• In vivo functioning of the Na+, K+-activated ATPase.

  1981cited by this paper
• Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: potential clamp analysis.

  1981cited by this paper
• Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.

  1981cited by this paper
• The (non)specificity in the lipid-requirement of calcium- and (sodium plus potassium)-transporting adenosine triphosphatases.

  1981cited by this paper
• Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

  1981cited by this paper
• Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men.

  1980cited by this paper
• Changes in Nerve Conduction Velocity After Six Weeks of Glucoregulation With Portable Insulin Infusion Pumps

  1980cited by this paper
• Diabetic Neuropathy—New Concepts of Its Etiology

  1979cited by this paper
• Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum.

  1979cited by this paper
• In Vitro Studies of the Substrates for Energy Production and the Effects of Insulin on Glucose Utilization in the Neural Components of Peripheral Nerve

  1979cited by this paper
• Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin.

  1979cited by this paper
• Phosphatidylinositol as the endogenous activator of the (Na+ + K+)-ATPase in microsomes of rabbit kidney.

  1978cited by this paper
• Myoinositol and function of peripheral nerves in human diabetics A CONTROLLED CLINICAL TRIAL

  1978cited by this paper
• Peripheral nerves in early experimental diabetes

  1978cited by this paper
• Effect of myo-inositol on peripheral-nerve function in diabetes.

  1978cited by this paper
• Nerve biopsy and conduction studies in diabetic neuropathy.

  1977cited by this paper
• Peripheral and Autonomic Nerve Function in Newly Diagnosed Diabetes Mellitus

  1977cited by this paper
• Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes.

  1976cited by this paper
• Compartments and barriers in the sciatic nerve of the rabbit.

  1976cited by this paper
• Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis.

  1976cited by this paper
• Diabetic neuropathy: clinical aspects.

  1976cited by this paper
• Hyperglycemia, polyol metabolism, and complications of diabetes mellitus.

  1975cited by this paper
• Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.

  1975cited by this paper
• Improvement in nerve conduction following treatment in newly diagnosed diabetics.

  1971cited by this paper
• Reversible nervous abnormalities in juvenile diabetics with recently diagnosed diabetes

  1971cited by this paper
• Electron microscopic study of galactose-induced cataract.

  1969cited by this paper
• Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients

  1968cited by this paper
• The oxygen consumption of mammalian non‐myelinated nerve fibres at rest and during activity

  1967cited by this paper

• Impact of glucagon-like peptide-1 receptor agonists on axonal function in diabetic peripheral neuropathy.

  2024cites this paper
• An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy

  2022cites this paper
• Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches

  2019cites this paper
• The Role of Sodium in Diabetic Cardiomyopathy

  2018cites this paper
• Experimental composite guidance conduits for peripheral nerve repair: an evaluation of ion release.

  2012cites this paper
• Diabetic peripheral neuropathies.

  2010cites this paper
• Axonal ion channels from bench to bedside: a translational neuroscience perspective.

  2009cites this paper
• Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.

  2008cites this paper
• Assessment of nerve excitability in toxic and metabolic neuropathies

  2008cites this paper
• A Comparative study on the Prevalence of Micro and Macro Vascular Complications among Type 2 Diabetic Patients With and Without Hypertension

  2007cites this paper
• Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease.

  2006cites this paper
• Modulation of Myo-[ 3 H ] inositol Uptake by Glucose and Sorbitol in Cultured Bovine Lens Epithelial Cells / . Restoration of Myo-inositol Uptake by A / dose Reductase Inhibition

  2005cites this paper
• Altered nerve excitability properties in established diabetic neuropathy.

  2005cites this paper
• Topical Review : New Trends in the Etiopathogenesis of Diabetic Peripheral Neuropathy

  2001cites this paper
• Aldose Reductase Inhibitors

  2001cites this paper
• Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.

  1999cites this paper
• Impairment of anorectal function in diabetes mellitus parallels duration of disease

  1999cites this paper
• A transgenic animal model of osmotic cataract. Part 1: over-expression of bovine Na+/myo-inositol cotransporter in lens fibers.

  1999cites this paper
• Acute hyperglycaemia affects anorectal motor and sensory function in normal subjects

  1997cites this paper
• Disturbances in anorectal function in patients with diabetes mellitus and faecal incontinence

  1996cites this paper
• Impaired rodent vagal nerve sodium-potassium-ATPase activity in streptozotocin diabetes.

  1995cites this paper
• Synthesis and aldose reductase inhibitory activity of 2-substituted 6-fluoro-2,3-dihydrospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dio nes.

  1995cites this paper
• Synthesis and aldose reductase inhibitory activity of 2-substituted-6-fluoro-2,3-dihydrospiro [4H-1-benzopyran-4, 4'-imidazolidine]-2',5'-diones.

  1994cites this paper
• Correlation of peripheral nerve fatigue following vibratory stimulation with hyperglycemia in diabetic patients.

  1994cites this paper
• Galactose and Ovarian Physiology

  1994cites this paper
• Rabbit optic nerve phosphorylates glucose through a glucokinase-like enzyme: studies in normal and spontaneously hyperglycemic animals.

  1994cites this paper
• Drugs designed to maintain the transparence of the ocular lens

  1994cites this paper
• Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness.

  1993cites this paper
• Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. I. Restoration of myo-inositol uptake by aldose reductase inhibition.

  1992cites this paper
• Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.

  1992cites this paper
• Effects of methylcobalamin on diabetic neuropathy.

  1992cites this paper
• Aldose reductase inhibitors and diabetic complications.

  1992cites this paper
• Biochemical basis of the diabetic embryopathy.

  1991cites this paper
• Effects of Polyol-Pathway Inhibition and Dietary myo-Inositol on Glomerular Hemodynamic Function in Experimental Diabetes Mellitus in Rats

  1991cites this paper
• Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos

  1990cites this paper
• The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus.

  1990cites this paper
• Effects of gangliosides on the methionine uptake in crushed sciatic nerves of rats with alloxan diabetes.

  1990cites this paper
• Correction of Altered Metabolic Activities in Sciatic Nerves of Streptozocin-Induced Diabetic Rats: Effect of Ganglioside Treatment

  1990cites this paper
• Diabetes and the myo-inositol Paradox

  1990cites this paper
• Diabetes and Hypertension

  1990cites this paper
• Glucose inhibition of human fibroblast proliferation and response to growth factors is prevented by inhibitors of aldose reductase.

  1989cites this paper
• Aldose reductase in the etiology of diabetic complications. 3. Neuropathy.

  1989cites this paper
• Aldose reductase in early streptozotocin-induced diabetic rat lens.

  1989cites this paper
• Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy.

  1989cites this paper
• Chronic exposure to high glucose decreases myo-inositol in cultured cerebral microvascular pericytes but not in endothelium

  1988cites this paper
• Diabetes Affects Sorbitol and myo-Inositol Levels of Neuroectodermal Tissue During Embryogenesis in Rat

  1988cites this paper
• ATPase Activity Defects in Alloxan-Induced Diabetic Sciatic Nerve Recovered by Ganglioside Treatment

  1988cites this paper
• Serum glucose concentration as a modulator of interdigestive gastric motility.

  1988cites this paper
• Effect of Increased Glucose Levels on Na+/K+‐Pump Activity in Cultured Neuroblastoma Cells

  1988cites this paper
• Hypertension and diabetes.

  1988cites this paper
• Na+-K+ pump in chronic renal failure.

  1987cites this paper
• Quantitative Histochemical Approaches Are Essential for Investigating Fundamental Questions of Diabetes Research

  1986cites this paper